|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 251.06 USD | -0.23% |
|
+6.94% | +9.88% |
| 04:48pm | Health Care Up on AI Rotation - Health Care Roundup | DJ |
| 12:44pm | Regenxbio Shares Rise on $100 Million Milestone Payment After First Patient Dosed in Eye-Disease Trial | DJ |
| Market Cap | 445B 390B 359B 335B 631B 42,269B 644B 4,322B 1,674B 20,748B 1,669B 1,633B 72,209B | P/E 2026 * |
31x | P/E 2027 * | 23.6x |
|---|---|---|---|---|---|
| Enterprise Value | 500B 439B 404B 377B 711B 47,575B 725B 4,864B 1,885B 23,352B 1,879B 1,838B 81,273B | EV / Sales 2026 * |
7.44x | EV / Sales 2027 * | 6.75x |
| Free-Float |
95.71% | Yield 2026 * |
2.75% | Yield 2027 * | 2.87% |
Last Transcript: AbbVie Inc.
| 1 day | -0.72% | ||
| 1 week | +6.94% | ||
| Current month | -0.23% | ||
| 1 month | +15.31% | ||
| 3 months | +15.44% | ||
| 6 months | +9.88% | ||
| Current year | +9.88% |
| 1 week | 233.66 |  | 255.99 |
| 1 month | 208.99 | | 255.99 |
| Current year | 190.75 | | 255.99 |
| 1 year | 184.63 | | 255.99 |
| 3 years | 132.7 | | 255.99 |
| 5 years | 105.56 | | 255.99 |
| 10 years | 55.06 | | 255.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Michael
CEO | Chief Executive Officer | 55 | 2024-06-30 |
Scott Reents
DFI | Director of Finance/CFO | 59 | 2022-06-22 |
Linda Ray
CTO | Chief Tech/Sci/R&D Officer | - | 2024-02-29 |
| Director | Title | Age | Since |
|---|---|---|---|
Roxanne Austin
BRD | Director/Board Member | 65 | 2012-12-31 |
Edward Rapp
BRD | Director/Board Member | 68 | 2012-12-31 |
| Director/Board Member | 72 | 2012-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05-07 | Free | Director | 1,118 | 0.0001% | ||
| 05-07 | Free | Director | 1,118 | 0.0001% | ||
| 05-07 | Free | Director | 1,118 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.23% | +6.94% | +35.25% | +86.34% | 445B | |
| -0.64% | +7.65% | +52.88% | +154.11% | 1,070B | |
| +0.00% | +6.23% | +66.27% | +53.44% | 611B | |
| -3.05% | +4.18% | +31.11% | +23.88% | 329B | |
| -1.74% | +1.94% | +36.90% | +22.86% | 290B | |
| -1.25% | +1.28% | +29.98% | +38.89% | 287B | |
| +2.99% | +5.28% | -26.30% | -41.06% | 213B | |
| -0.22% | +4.13% | +29.41% | +62.75% | 195B | |
| -0.29% | +0.74% | +13.62% | +63.45% | 157B | |
| -0.83% | -3.40% | -1.49% | -34.90% | 137B | |
| Average | -0.59% | +4.26% | +26.76% | +42.98% | 373.35B | |
| Weighted average by Cap. | -0.66% | +6.32% | +38.67% | +72.38% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 67.24B 59.03B 54.34B 50.63B 95.49B 6,392B 97.43B 654B 253B 3,138B 252B 247B 10,920B | 72.73B 63.86B 58.78B 54.77B 103B 6,915B 105B 707B 274B 3,394B 273B 267B 11,813B |
| Net income | 14.56B 12.78B 11.77B 10.97B 20.68B 1,384B 21.1B 142B 54.84B 680B 54.67B 53.49B 2,365B | 19.02B 16.7B 15.37B 14.33B 27.02B 1,809B 27.57B 185B 71.64B 888B 71.43B 69.88B 3,090B |
| Net Debt | 55.81B 49B 45.1B 42.03B 79.26B 5,306B 80.87B 542B 210B 2,604B 210B 205B 9,064B | 46.34B 40.68B 37.45B 34.89B 65.81B 4,405B 67.14B 450B 175B 2,162B 174B 170B 7,526B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-01 | US$251.06 | -0.23% | 6,982,662 |
| 26-06-30 | US$251.64 | -1.05% | 6,999,707 |
| 26-06-29 | US$254.31 | +0.38% | 9,760,531 |
| 26-06-26 | US$253.35 | +4.20% | 52,635,078 |
| 26-06-25 | US$243.14 | +3.51% | 10,281,847 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABBV Stock
Select your edition
All financial news and data tailored to specific country editions
